Answers are grounded in this paper and cite their sources.
The article aims to examine technological, organizational and regulatory aspects of drug quality and safety assurance system, as well as peculiarities in civil circulation of extemporaneous drugs in Latvian pharmaceutical market to improve approaches for statutory regulation of this special and socially significant type of activity of pharmaceutical organizations. This work continues a series of articles about compounding pharmacy practice in different world healthcare systems.
No takes yet. Share an insight, caveat, or question.
Mamedov et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: